MRN build global Site Network – expanding patient access to clinical trials in new communities.
Milton Keynes (29 August 2024) – Today, UK based Medical Research Network (MRN), the innovative market-leader of international community-based clinical trial delivery, announces the launch of their rapidly-growing global site network.
Known for their in-home trial delivery and on-site resource solutions, MRN’s global site network is creating the most efficient ecosystem for clinical trials by engaging experienced, trial naïve, and virtual research sites. All network sites are provided with appropriate training and technology to be research ready and supported to run in-home trial visits supported by a highly skilled and experienced project management team and empowered by MRN owned and operated regulatory approved eClinical solutions.
Caroline Potts, General Manager of Site & Patients Services at MRN said: “This is truly changing the paradigm of how we conduct clinical trials. Our aim is to create the most comprehensive, global, supported and trained network of experienced and trial naïve research sites. Today, this network stands at 60 sites across the US, UK & Canada and is continuing to grow rapidly; by year end the network will contain over 100 sites and added in coverage across Spain, France, Germany, Italy and the Netherlands. Our global network of trained and research ready sites, plus our ongoing in-home and at-site support solutions will remove barriers for patients and sites who want to participate in clinical research”.
Stuart Redding, CEO of MRN added: “We are providing the industry a vehicle to discover untapped communities and increase trial access for more patients, improving recruitment and retention and supporting diverse patient populations. The solutions we offer will always look to accelerate clinical trials by addressing key challenges for each protocol; through our Site Network, Home Trial Support and eClinical capabilities, we can create a customized approach to maximize trial speed and efficiency, getting drugs to the market faster”.
MRN have been the pioneers of community-based clinical trials for the Pharmaceutical Industry, first bringing their solutions to the market in 2006. MRN’s services are designed to impact two of the most important issues facing clinical trials today – patient recruitment and retention. Through a portfolio of highly managed solutions, MRN creates more accessible and flexible clinical trials that can be delivered in any community around the world.
This announcement furthers MRN’s mission to provide the Pharmaceutical Industry a gold standard platform of clinical trial services designed to work together in synergy, bringing trials closer to patients, while making trials faster, more efficient, more inclusive and more accessible for all patients and all research sites around the world. MRN has offices in the UK, France, Spain, Germany, USA, and Japan and provides local services across all major clinical research countries spanning North America, Europe, Asia, and Australasia.
About MRN
MRN accelerates patient recruitment and improves patient engagement and retention through site-centric and patient-centric solutions. As an innovative market-leader, MRN provides customized solutions to optimize each individual protocol and create more flexible, efficient, and accessible clinical trials that deliver accelerated timelines. Through integrated in-home visit delivery and a vast global network of trained, research ready sites, all empowered by MRN’s digital solutions, MRN engages with and empowers diverse communities around the world to participate in and advance medical research.
Click here to learn more about MRN Site Network
For more information about MRN or to initiate an RFP for an upcoming trial, email enquires@themrn.co.uk
Media Contact
Medical Research Network
Laura Lange
Executive Director, Marketing
Marketing@themrn.co.uk